Saya Biologics Press Releases - EIN Presswire - Press Release Distribution Service

Published on February 4, 2026 - 05:42 GMT

Saya Biologics and Kashiv BioSciences partner to bring a biosimilar supportive oncology therapy to Mexico and CAC

Supportive oncology therapies help cancer patients maintain treatment continuity by managing common chemotherapy-related complications. MEXICO CITY, MEXICO CITY, MEXICO, February 4, 2026 /⁨EINPresswire.com⁩/ -- Saya Biologics (Saya Bio), a Mexican …

Distribution channels: Business & Economy, Companies ...

Published on January 26, 2026 - 14:26 GMT

Saya Biologics and Hybio Pharmaceutical partner to expand access to GLP-1 generic in Mexico

GLP-1 therapies are a cornerstone for the management of type 2 diabetes, supporting glycemic control and improving patients’ quality of life. MEXICO CITY, MEXICO, January 26, 2026 /⁨EINPresswire.com⁩/ -- Saya Biologics (Saya Bio), a Mexican …

Distribution channels: Business & Economy, Companies ...

Published on December 4, 2025 - 16:25 GMT

Mexico will receive new biosimilars for bone health through Saya Biologics in collaboration with Enzene, a CDMO partner

Collaboration aims to drive growth in the biosimilars market across Latin America and broaden access to biologic therapies for bone and joint diseases.  MEXICO CITY, MEXICO CITY, MEXICO, December 4, 2025 /⁨EINPresswire.com⁩/ -- Saya Biologics (“Saya Bio …

Distribution channels: Business & Economy, Companies ...

Published on November 26, 2025 - 23:09 GMT

Saya Biologics and Innovent Biologics announce strategic collaboration to expand access to oncology therapies in Mexico

Saya Biologics will register and commercialize Bevacizumab in Mexico, while Innovent Biologics will develop and supply the oncology biosimilar product. MEXICO CITY, MEXICO CITY, MEXICO, November 26, 2025 /⁨EINPresswire.com⁩/ -- Saya Biologics (Saya Bio …

Distribution channels: Business & Economy, Companies ...